Central Nervous System Therapeutics Market
Central Nervous System Therapeutics Market Research Report By Therapeutic Area (Neurodegenerative Diseases (Alzheimer's disease, Parkinson's disease, Multiple sclerosis), Neuropsychiatric Disorders (Depression, Anxiety, Schizophrenia), Neurological Disorders (Stroke, Epilepsy, Spinal cord injuries), Pain Management, Neuro-Oncology), By Drug Class (Monoclonal Antibodies, Neuroprotectants, Anticonvulsants, Antidepressants, Anxiolytics, Antipsychotics), By Route of Administration (Oral, Intravenous, Transdermal, Inhalational, Subcutaneous), By Patient Population (Adults, Pediatrics, Geriatrics, Specific Patient Groups (e.g., treatment-resistant patients, patients with co-morbidities)) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032
Global Central Nervous System Therapeutics Market Overview
As per MRFR analysis, the Central Nervous System Therapeutics Market Size was estimated at 147.79 (USD Billion) in 2022.ย
The Central Nervous System Therapeutics Industry is expected to g..